Gareth J Morgan, PhD

Research Assistant Professor, Medicine

Gareth Morgan


Gareth Morgan, PhD is a Research Assistant Professor at the Boston University School of Medicine. His research focuses on the molecular mechanisms of AL amyloidosis with the aim of developing new treatments for this disease.

Other Positions

  • Member, BU-BMC Cancer Center, Boston University
  • Member, Amyloidosis Center, Boston University
  • Member, Genome Science Institute, Boston University
  • Graduate Faculty (Primary Mentor of Grad Students) , Boston University School of Medicine, Graduate Medical Sciences


  • University of Sheffield, PhD
  • Imperial College London, BS


  • Published on 10/30/2021

    Morgan GJ. Transient disorder along pathways to amyloid. Biophys Chem. 2022 Feb; 281:106711. PMID: 34839162.

    Read at: PubMed
  • Published on 6/11/2021

    Morgan GJ. Barriers to Small Molecule Drug Discovery for Systemic Amyloidosis. Molecules. 2021 Jun 11; 26(12). PMID: 34208058.

    Read at: PubMed
  • Published on 5/3/2021

    Yan NL, Santos-Martins D, Nair R, Chu A, Wilson IA, Johnson KA, Forli S, Morgan GJ, Petrassi HM, Kelly JW. Discovery of Potent Coumarin-Based Kinetic Stabilizers of Amyloidogenic Immunoglobulin Light Chains Using Structure-Based Design. J Med Chem. 2021 05 13; 64(9):6273-6299. PMID: 33939422.

    Read at: PubMed
  • Published on 9/12/2020

    Morgan GJ, Wall JS. The Process of Amyloid Formation due to Monoclonal Immunoglobulins. Hematol Oncol Clin North Am. 2020 12; 34(6):1041-1054. PMID: 33099422.

    Read at: PubMed
  • Published on 6/16/2020

    Yan NL, Santos-Martins D, Rennella E, Sanchez BB, Chen JS, Kay LE, Wilson IA, Morgan GJ, Forli S, Kelly JW. Structural basis for the stabilization of amyloidogenic immunoglobulin light chains by hydantoins. Bioorg Med Chem Lett. 2020 08 15; 30(16):127356. PMID: 32631553.

    Read at: PubMed
  • Published on 8/14/2019

    Rennella E, Morgan GJ, Yan N, Kelly JW, Kay LE. The Role of Protein Thermodynamics and Primary Structure in Fibrillogenesis of Variable Domains from Immunoglobulin Light Chains. J Am Chem Soc. 2019 08 28; 141(34):13562-13571. PMID: 31364359.

    Read at: PubMed
  • Published on 4/10/2019

    Morgan GJ, Yan NL, Mortenson DE, Rennella E, Blundon JM, Gwin RM, Lin CY, Stanfield RL, Brown SJ, Rosen H, Spicer TP, Fernandez-Vega V, Merlini G, Kay LE, Wilson IA, Kelly JW. Stabilization of amyloidogenic immunoglobulin light chains by small molecules. Proc Natl Acad Sci U S A. 2019 04 23; 116(17):8360-8369. PMID: 30971495.

    Read at: PubMed
  • Published on 12/31/2018

    Rennella E, Morgan GJ, Kelly JW, Kay LE. Role of domain interactions in the aggregation of full-length immunoglobulin light chains. Proc Natl Acad Sci U S A. 2019 01 15; 116(3):854-863. PMID: 30598439.

    Read at: PubMed
  • Published on 3/1/2018

    Buxbaum JN, Morgan GJ. Summary: FASEB Science Research Conference on Protein Aggregation in Health and Disease. FASEB J. 2018 03; 32(3):1125-1129. PMID: 29521540.

    Read at: PubMed
  • Published on 12/4/2017

    Morgan GJ, Usher GA, Kelly JW. Incomplete Refolding of Antibody Light Chains to Non-Native, Protease-Sensitive Conformations Leads to Aggregation: A Mechanism of Amyloidogenesis in Patients? Biochemistry. 2017 Dec 19; 56(50):6597-6614. PMID: 29200282.

    Read at: PubMed

View 12 more publications: View full profile at BUMC

View all profiles